Goldman Sachs has downgraded Ultragenyx Pharmaceutical (RARE) to neutral from buy citing disappointing phase 3 trial results released in December for seralutinib as a treatment for the rare genetic ...
In this tutorial, we explore the capabilities of the pymatgen library for computational materials science using Python. We begin by constructing crystal structures such as silicon, sodium chloride, ...
If there’s one universal experience with AI-powered code development tools, it’s how they feel like magic until they don’t. One moment, you’re watching an AI agent slurp up your codebase and deliver a ...
Amazon audiences will be trending on Netflix soon. On Wednesday, Amazon Ads announced that, starting next quarter, US media buyers will be able to tap Amazon Audiences for targeting when they run ...
MWC 2026 | Fibocom and du's ALL-IN-ONE AI CPE Solution Reinvents Family Data Interaction with AI NAS
BARCELONA, Spain, March 4, 2026 /PRNewswire/ -- On March 4, during the 2026 Mobile World Congress (MWC), Fibocom&du's ALL-IN-ONE AI CPE solution continued to draw attention with its AI NAS upgrade, ...
DANVILLE, Pa. — Geisinger Health and Nuance Communications, an information technology vendor for the healthcare group, agreed to pay $5 million to settle a class action lawsuit stemming from a former ...
Graphs are everywhere. From technology to finance, they often model valuable information such as people, networks, biological pathways and more. Often, scientists and technologists need to come up ...
The newly developed Huber mean provides a more stable and reliable way to compute averages for data lying on curved geometric spaces, or Riemannian manifolds. By combining the strengths of ...
As AI becomes more common and decisions more data-driven, a new(ish) form of information is on the rise: synthetic data. And some proponents say it promises more privacy and other vital benefits. Data ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
World’s First IND Approval in Oncology Based Solely on Human Vascularized Organoid Efficacy Data Confirms Shift Toward Human-Relevant Preclinical Testing SAN DIEGO, Calif. – October 27, 2025 – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results